Pharmacologic treatment of central post-stroke pain

The Clinical Journal of Pain
A FreseS Evers

Abstract

Almost 100 years after the first report of the thalamic syndrome, the scientific basis for the treatment of central post-stroke pain (CPSP) is remarkably small. Therefore, the authors aimed to provide evidence-based recommendations for the treatment of CPSP. The authors performed a systematic review of the literature on the pharmacologic treatment of CPSP. All studies and case series were included and evaluated according to their level of evidence. Only CPSP was considered, not other types of central pain. Amitriptyline and lamotrigine are the only oral drugs proven to be effective in the treatment of CPSP in a placebo-controlled study. IV drugs such as lidocaine, propofol, and ketamine have shown efficacy for short-term control of CPSP, but their application and potential side effects make them unsuitable for long-term treatment. The novel antiepileptic drug gabapentin has been reported to control CPSP in a few patients. Amitriptyline, lamotrigine, and gabapentin provide a more favorable efficacy and safety profile than the classic antiepileptic drugs carbamazepine and phenytoin, for which no placebo-controlled evidence of efficacy was found. Clinical trials are urgently needed to optimize pharmacologic treatment of CPSP.

References

May 7, 1992·The New England Journal of Medicine·M B MaxR Dubner
Dec 1, 1990·The International Journal of Neuroscience·G I Awerbuch, R Sandyk
Jun 1, 1988·Neurology·J BogousslavskyA Uske
Feb 1, 1985·Neuropeptides·D E MyersR L Wynn
Dec 9, 1972·British Medical Journal·F K Cantor
Oct 21, 1974·JAMA : the Journal of the American Medical Association·E K Mladinich
May 1, 1995·Pain·Grethe AndersenTroels Staehelin Jensen
Jun 1, 1995·Stroke; a Journal of Cerebral Circulation·E KumralK Kumral
Mar 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·R J DavenportP J Galloway
Mar 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·T TairaK Takakura
Oct 1, 1993·Southern Medical Journal·E A EdmondsonA Beric
Feb 15, 1993·European Journal of Pharmacology·N Suman-ChauhanG N Woodruff
Dec 1, 1995·Neurology·G R Gonzales
Oct 1, 1995·Postgraduate Medical Journal·D Bowsher
Sep 1, 1995·Journal of Neurology·S CanaveroS Vighetti
Mar 1, 1996·American Journal of Physical Medicine & Rehabilitation·F Y Chiou-TanJ R Strayer
Jul 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·D Bowsher
Feb 1, 1996·Pain·S CanaveroG Castellano
Jan 1, 1995·Stereotactic and Functional Neurosurgery·T TairaK Takakura
Dec 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·G D Schott
Nov 1, 1996·Pain·S Canavero, V Bonicalzi
Apr 29, 1998·Epilepsy Research·C P TaylorL Singh
Jul 29, 1998·Neuropharmacology·A StefaniG Bernardi
Apr 22, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P B CarrieriR Bruno
May 20, 2000·Acta Neurologica Scandinavica. Supplementum·R N Harden
Jun 1, 2000·Palliative Medicine·N Holtom

❮ Previous
Next ❯

Citations

Feb 27, 2008·Der Nervenarzt·B WormlandG D Borasio
Jan 20, 2012·Journal of General Internal Medicine·Claire J CreutzfeldtMelanie Walker
Jul 31, 2013·Neurocritical Care·Axel Petzold, Armand Girbes
Feb 26, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Sang Pil Yun, Bong Chul Sun
Aug 9, 2012·Journal of Palliative Medicine·Julie Hauer, Daniel Mackey
Mar 14, 2013·QJM : Monthly Journal of the Association of Physicians·J S BalamiA M Buchan
Oct 22, 2008·Annual Review of Medicine·Michael W O'DellVictoria Harrison
Jul 28, 2010·Journal of Neurophysiology·Raimi L QuitonAsaf Keller
Mar 14, 2008·CNS Drugs·Walter Pöllmann, Wolfgang Feneberg
May 1, 2009·Expert Review of Neurotherapeutics·Jong S Kim
Nov 16, 2007·Expert Opinion on Pharmacotherapy·Paul Gray
Sep 18, 2012·Mayo Clinic Proceedings·Grant W MalloryKendall H Lee
Oct 9, 2012·Neurophysiologie clinique = Clinical neurophysiology·L Garcia-Larrea
May 15, 2012·Neuroscience Letters·Luis Garcia-Larrea
Jan 21, 2011·Lancet Neurology·Joyce S BalamiAlastair M Buchan
Jul 22, 2009·Pharmacology, Biochemistry, and Behavior·Fabio DamascenoOlga M M S de Almeida
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Helen M DeweyJanice M Collier
May 21, 2014·Journal of Oral Rehabilitation·U KotirantaT Kauppila
May 13, 2015·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·HyunSoo Oh, WhaSook Seo
Jul 15, 2015·Acta neurochirurgica·A Rezaei HaddadK Ashkan
Oct 25, 2014·The Tohoku Journal of Experimental Medicine·Sea-Hyun BaeKyung-Yoon Kim
Apr 22, 2015·Nature Reviews. Neurology·Koichi HosomiYouichi Saitoh
Apr 4, 2015·Neurobiology of Disease·Yung-Hui KuanBai-Chuang Shyu
Sep 20, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A SiniscalchiE Santangelo
Sep 24, 2013·Neuroscience Research·Tomoko HanadaAtsuro Miyata
Dec 25, 2012·Archives of Physical Medicine and Rehabilitation·Wai Kwong TangKa-Sing Wong
Aug 28, 2010·Topics in Stroke Rehabilitation·Richard L Harvey
Sep 12, 2013·Pain·Luis Garcia-Larrea, Roland Peyron
May 7, 2016·Biological & Pharmaceutical Bulletin·Wataru MatsuuraShogo Tokuyama
Mar 29, 2014·Stroke; a Journal of Cerebral Circulation·Robert G HollowayUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology
Sep 12, 2015·Stroke; a Journal of Cerebral Circulation·Sohail M MullaJason W Busse
Dec 27, 2011·American Journal of Therapeutics·Bill McCarbergCarolyn Zaleon
Sep 1, 2017·The Journal of Pharmacology and Experimental Therapeutics·Ya-Qun ZhouDa-Wei Ye
Nov 14, 2019·Current Neurology and Neuroscience Reports·Alyson R PlecashThalia S Field
Apr 18, 2009·Anesthesia and Analgesia·Bishwanath KumarUsha K Misra
Oct 13, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Karen-Amanda Irvine, J David Clark
Feb 8, 2021·CNS Drugs·Hanwool Ryan ChoiMichael M Bottros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.